Sykon Capital LLC Pro Phase Labs, Inc. Transaction History
Sykon Capital LLC
- $300 Billion
- Q3 2025
A detailed history of Sykon Capital LLC transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Sykon Capital LLC holds 644,795 shares of PRPH stock, worth $193,438. This represents 0.1% of its overall portfolio holdings.
Number of Shares
644,795
Previous 644,795
-0.0%
Holding current value
$193,438
Previous $252 Million
16.99%
% of portfolio
0.1%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding PRPH
# of Institutions
30Shares Held
2.98MCall Options Held
13.7KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA532KShares$159,5750.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA398KShares$119,3740.0% of portfolio
-
Geode Capital Management, LLC Boston, MA303KShares$90,8780.0% of portfolio
-
Accretive Wealth Partners, LLC Parsippany, NJ250KShares$75,0000.04% of portfolio
-
High Tower Advisors, LLC Chicago, IL237KShares$71,2010.0% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $4.81M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...